Traditional CROs fragment device development with costly hand-offs and learning curves. Veranex unites the essential disciplines for medical device & diagnostic development under one roof from sketch to evidence-generation to market launch.
All connected. All aligned. All accelerating your path to market—delivering breakthrough devices and diagnostics that improve patient lives sooner.
Breakthrough innovation requires more than great solutions; it demands deep expertise and insight. Veranex packages outcome-driven solutions with 25+ years of specialized knowledge across major medtech categories, delivering integrated capabilities that solve your most pressing challenges faster and with greater certainty.
Purpose-built solutions. Proven results. User & Patient-centered innovation.
Whether you're transforming patient care or disrupting entire therapeutic categories, innovation requires more than great science, it demands velocity. Veranex was founded to bridge the gap between visionary concepts and market reality, combining proven expertise with agile execution to accelerate the innovations that matter most.
We are the Innovation CRO.
Legacy of excellence. Proven execution. Patient impact accelerated.
From early feasibility to commercialization, progress depends on the right decisions at the right time. Get confident in your next step with blogs, case studies, and expert insights that cut through complexity and move development forward.
Specify and justify the minimum level of clinical evidence required basedon device characteristics and intended purpose.
Identify when different clinical evaluation strategies (e.g., clinical investigations, equivalence, well-established technology, or Article 61(10)) may or may not be appropriate to demonstrate conformity with the relevant GSPRs.
Overview of MDR Article 61 requirements and the concept of the "appropriate level of clinical evidence".
Factors influencing the selection of a clinical evaluation strategy.
Clinical evaluation strategies available under the MDR.
Regulatory expectations, advantages, limitations, and justification requirements for each strategy.
Practical examples and case studies illustrating when each clinical evaluation strategy may or may not be suitable and how the rationale should be documented.
Regulatory Affairs and Clinical Affairs professionals working for medical device manufacturers seeking to place devices on the European Union (EU) market.
Learn from Specialists Who Work Inside Medtech Complexity Every Day
Talk with Veranex about upcoming training dates, private sessions, or tailored programs built around your organization’s device, IVD, regulatory, clinical, or quality needs.
